Abstract:
Background: Only four out of 31 completed randomized controlled trials (RCTs) of HIV
prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the
impact of various levels of adherence on measured efficacy within an RCT.
Analysis: We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100% adherence the measured efficacy within an RCT is a reasonable approximation of the true
biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60% adherence, the measured efficacy can be less than half of the true biological efficacy.
Conclusion: Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There
are currently 12 ongoing HIV prevention trials, all but one of which require ongoing useradherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.
